OGEN - .545 Pre-market now at .5951/.60 Oragenics Enrolls More Than 80 Patients for Mid-Stage Trial of Lead Compound AG013 for Oral Mucositis - Stock Rises 9% https://www.tradescores.com/StockReport/ogen